ebia Electrophoresis is 100% focused on the science of electrophoresis.
At least 10% of the annual budget is dedicated to research and development resulting in a
continuous stream of new and innovative electrophoresis product introductions. What’s new at Sebia?
Expanding line of Capillary Electrophoresis (CE)
Technology:
The MINICAP
instrument represents the latest evolution in Sebia’s innovative line of
CE technology, which also includes the CAPILLARYS™ 2. The MINICAP offers sophisticated,
completely walk-away automation with a small instrument footprint.
News from the FDA:
Sebia has received clearance from the Food and Drug Administration (FDA) to market the
MINICAP Protein 6 assay
– for the separation and quantitation of the six major serum protein fractions.
Separation and direct detection of serum proteins take place with the newly
released MINICAP instrument
Sebia has received clearance from the FDA to market the
CAPILLARYS™ Hemoglobin assay.
Utilized with the
CAPILLARYS 2 instrument,
CAPILLARYS Hemoglobin aids in the diagnosis of hemoglobinopathies and thalassemias and is designed to separate,
detect, and quantify normal hemoglobins and hemoglobin variants.
Sebia has received clearance from the FDA to market the
CAPILLARYS Urine kit,
which allows for the separation of urine proteins by capillary electrophoresis technology.
View a
video introduction to CAPILLARYS 2
technology.
Sebia has received FDA clearance to market the
HYDRAGEL® A1AT Isofocusing
kit designed for the qualitative detection and identification of different phenotypes of A1AT.
This marks the first FDA cleared kit for A1AT Phenotyping. Phenotyping results, in conjunction with clinical findings and other
laboratory assays, aid in the diagnosis of A1AT deficiency –
the most common genetic cause of liver disease in children. A set of three FDA cleared A1AT Controls are also available.
Business Partnerships:
We would like to welcome each Beckman-Coulter electrophoresis customer to Sebia Electrophoresis.
To help support this transition process we have established a separate email address
(BC@Sebia-usa.com) for questions regarding the Beckman-Coulter and Sebia collaboration or
you could call us directly at 1-800-835-6497 and ask for the Sebia Transition Team for Paragon Products.
Welcome to the Sebia family and we look forward to working with you and your laboratory!
| 
